CD4 and systemic inflammatory response syndrome: Patients in whom postoperative administration exceeded the 7-day increased the level of CD4+, CD4+/CD8+, IgM, IgG, lymphocyte and proalbumin levels. SIRS and postoperative complications were reduced in the IEN group.